What Geistlich Biomaterials does

Geistlich Biomaterials is the North American commercial arm of Swiss family-owned Geistlich Pharma AG, which has operated continuously since 1851 and now employs more than 800 people worldwide, with global headquarters and primary manufacturing in Wolhusen, Switzerland, and a regional headquarters (Geistlich Pharma North America, GPNA) in Princeton, NJ, established to serve the United States and Canada. The company develops and manufactures regenerative medical devices derived from processed xenograft tissue — principally Australian extremity-sourced bovine bone processed into Geistlich Bio-Oss bone substitute, and Swiss-sourced porcine collagen processed into Geistlich Bio-Gide membranes and the Mucograft/Fibro-Gide soft-tissue matrices — together with combination kits, Meisinger fixation hardware, bone harvesting instruments, RPM reinforced PTFE mesh, and Yxoss CBR patient-specific 3D-printed titanium scaffolds. A separate Geistlich Nexo-Gide dual-surface collagen membrane extends the platform into surgical and sports medicine. All tissue processing occurs at two sites in central Switzerland under ISO 9001/13485 quality management and EDQM TSE certification, with U.S.-distributed products sold under FDA clearance.

Geistlich sells primarily to dental professionals — periodontists, oral surgeons, and general dentists performing bone and soft-tissue regeneration around dental implants, periodontal defects, extraction sockets, and sinus floor elevations — and secondarily to surgical/sports medicine specialists, advanced wound-care providers, and U.S. government and military healthcare buyers. The company describes itself as the global market leader in regenerative dentistry, with cumulative use across more than 25 million patients (data on file, Geistlich Pharma AG), 2,800+ scientific publications validating its products, and a reported usage rate of one Geistlich product every 14 seconds worldwide. Customer and KOL engagement is reinforced by three co-founded foundations — the Osteology Foundation (2003), Osteo Science Foundation (2013), and ON Foundation (2018) — funding research and education in regenerative dentistry and orthoregeneration.

The commercial model is direct, geographically stratified, and account-based. GPNA runs a dedicated U.S./Canada field sales organization backed by clinical education programs, trade-show presence, webinars, and a digital eShop at geistlich.us; exclusive distribution arrangements cover HANSAmed in Canada and Buffalo Supply Inc. for U.S. government and Federal Supply Schedule contracts. Globally, Geistlich reaches customers through 15 country affiliates and roughly 60 third-party distributors across North America, Europe, Asia Pacific, and Latin America. Revenue is generated through one-time product sales to professional accounts; pricing is not publicly disclosed and is managed through the GPNA account system. The company is 100% family-owned with no external investors, led by CEO Diego Gabathuler, CFO Jürg Roth, CSO Dr. Mark Spilker, and Chairman Dr. Andreas Geistlich.

Name

Geistlich Biomaterials

Legal name

Geistlich Pharma North America, Inc.

Website

https://geistlich-na.com

Company type

Private

Founded year

1851

Operating status

Operating

Headcount range

101–250 employees

Short description

Geistlich Biomaterials is the North American subsidiary of Swiss family-owned Geistlich Pharma AG (operating since 1851), producing bovine bone substitutes and porcine collagen membranes for dental and sports-medicine regeneration, distributed globally via 15 affiliates and roughly 60 partners.

Ownership category

akta.pro rank

Product category

Regenerative Dental Biomaterials

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Bone Graft Substitutes & Orthobiologics (Synthetic/Allograft/DBM) (HLAHAEAG)

akta.pro secondary industries

Cartilage, Bone & Musculoskeletal Regeneration (HLAAAGAH), Skin Substitutes & Biologic/Regenerative Wound Therapies (Matrices, Grafts) (HLAHALAE), Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA)

Keywords

• Regenerative biomaterials
• Bone graft substitutes
• Collagen membranes
• Xenograft dental products
• Soft tissue regeneration

Headquarters

HQ city

Princeton

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Operations

Revenue model

1. Biomaterial Product Sales: Geistlich generates revenue primarily through the sale of regenerative biomaterial medical devices, including bone substitutes (Geistlich Bio-Oss, Geistlich Bio-Oss Collagen), collagen membranes (Geistlich Bio-Gide family), matrices (Mucograft, Mucograft Seal, Fibro-Gide), and the surgical/sports medicine product Geistlich Nexo-Gide. Products are sold directly through GPNA in the U.S. and through distributors in Canada and other markets.
2. Dental Professional Product Sales: Dental professionals (periodontists, oral surgeons, general dentists) purchase Geistlich products directly for use in regenerative dental procedures. GPNA manages these accounts with a dedicated sales force and customer care team (855-799-5500).

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Geistlich Biomaterials develops, manufactures, and sells regenerative medical devices derived from xenogeneic (bovine bone and porcine collagen) sources for use in dental, oral-surgical, orthopedic, and wound-care applications. Its core offerings include bone substitutes (Geistlich Bio-Oss family), collagen membranes (Geistlich Bio-Gide family), soft-tissue matrices (Mucograft, Mucograft Seal, Fibro-Gide), and the dual-surface sports-medicine membrane Geistlich Nexo-Gide. These products serve as scaffolds that enable natural bone and soft-tissue regeneration in procedures such as dental implant placement, periodontal therapy, sinus floor elevation, and tendon repair.

Product overview

Geistlich Biomaterials is a Swiss family-owned company (founded 1851) specializing in regenerative biomaterials. The company offers a comprehensive portfolio of medical devices organized into four main categories: Bone Substitutes (including Geistlich Bio-Oss, Geistlich Bio-Oss Pen, Geistlich Bio-Oss Collagen, Geistlich vallomix, and vallos), Collagen Membranes (including Geistlich Bio-Gide, Geistlich Bio-Gide Compressed, Geistlich Bio-Gide Perio, Geistlich Bio-Gide Shape), Soft-tissue Matrices (including Mucograft, Mucograft Seal, Fibro-Gide), and Surgical Accessories (including bone harvesting instruments, fixation systems, and 3D customized titanium mesh). Additionally, Geistlich offers Geistlich Nexo-Gide for surgical and sports medicine applications. The company's anchor technologies—Geistlich Bio-Oss for bone regeneration and Geistlich Bio-Gide for tissue protection—form the foundation of their regenerative medicine portfolio. Geistlich operates globally with 15 affiliates and 60 distributors, serving dental professionals, surgical/sports medicine professionals, and wound care markets.

Differentiator

Problem solved

Functional benefit

Brands

• Geistlich Bio-Oss: Bone substitute material for bone regeneration in dental procedures
• Geistlich Bio-Oss Pen
• Geistlich Bio-Oss Collagen
• Geistlich Bio-Gide
• Geistlich Bio-Gide Compressed
• Geistlich Bio-Gide Perio
• Geistlich Bio-Gide Shape
• Geistlich Mucograft
• Geistlich Mucograft Seal
• Geistlich Fibro-Gide
• Geistlich Nexo-Gide
• Geistlich vallomix
• vallos
• Geistlich Combi-Kit
• Geistlich Perio-System Combi-Pack
• Geistlich Orthoss

Products and services

• Geistlich Bio-Oss Bovine-derived bone substitute material used for bone regeneration in dental and orthopedic applications; preserves the natural microstructure and composition of bone for osteoconductive regeneration.
• Geistlich Bio-Oss Pen Geistlich Bio-Oss bone substitute material delivered via a pen applicator for convenient handling during dental bone augmentation procedures.
• Geistlich Bio-Oss Collagen Bone substitute combining bovine bone mineral with collagen for easier handling and application in bone regeneration procedures.
• Geistlich vallomix Bone substitute material for dental bone regeneration applications.
• vallos Bone substitute material for dental regeneration procedures.
• Geistlich Bio-Gide Porcine collagen membrane used for guided tissue and bone regeneration; features a dual-surface design with a smooth upper surface and porous lower layer to support wound healing and tissue integration.
• Geistlich Bio-Gide Compressed Compressed version of the Geistlich Bio-Gide collagen membrane offering enhanced handling characteristics for specific surgical applications.
• Geistlich Bio-Gide Perio Collagen membrane variant specifically designed for periodontal applications in dental regeneration.
• Geistlich Bio-Gide Shape Pre-shaped collagen membrane variant designed for specific anatomical applications in dental procedures.
• Geistlich Mucograft Porcine collagen matrix designed for soft-tissue regeneration, used in procedures such as root coverage, alveolar ridge preservation, and recession coverage as an alternative to palate tissue grafts.
• Geistlich Mucograft Seal Collagen matrix designed for soft-tissue sealing applications, particularly for socket preservation after tooth extraction.
• Geistlich Fibro-Gide Porcine collagen matrix designed for soft-tissue augmentation and volume enhancement in dental applications.
• Geistlich Nexo-Gide FDA-cleared, resorbable, dual-surface porcine collagen bilayer membrane with a smooth upper surface and porous lower surface, used for management and protection of tendon injuries in surgical and sports medicine applications.
• Geistlich Combi-Kit Combination kit pairing Geistlich Bio-Oss bone substitute with a Geistlich Bio-Gide collagen membrane for guided bone regeneration procedures.
• Geistlich Perio-System Combi-Pack Combined bone substitute and membrane system packaged for periodontal regeneration procedures.
• Yxoss CBR 3D customized titanium mesh scaffold designed for patient-specific bone regeneration in dental applications.
• Bone Harvesting Instruments Surgical instruments designed for harvesting autogenous bone during oral surgical procedures.
• Meisinger Screws and Screw Fixation System TX Surgical screws and fixation system for membrane and bone block stabilization in regenerative dental procedures.
• Meisinger Pins and Master-Pin-Control System Pin fixation system for membrane stabilization and tissue management in oral surgery.

Quantifiable outcome

• A Geistlich product is used every 14 seconds globally
• +4 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Six partnerships are on record, tiered core.

• HANSAmed LimitedcoreChannel Partner/ Reseller/ DistributorHANSAmed Limited is the exclusive Canadian distributor of Geistlich Biomaterials. Based in Canada, HANSAmed serves the dental professional community in Canada, focusing on pain management, bone regeneration, periodontics, and compliance. The partnership enables Geistlich to serve the Canadian market through a specialized distributor.
• Buffalo Supply Inc.coreChannel Partner/ Reseller/ DistributorBuffalo Supply Inc. serves the U.S. government and military through partnership with Geistlich Pharma North America. The company optimizes procurement and ensures compliance for a wide range of government customers, handling Federal Supply Schedule (FSS) contracts and streamlining government business for Geistlich products.
• Osteology FoundationcoreStrategic or Co-development PartnerFounded in 2003 by Dr. Peter Geistlich and Geistlich Pharma AG, the Osteology Foundation promotes teaching and research and brings science and practice closer together in the field of bone and soft-tissue regeneration. Geistlich co-founded and actively supports this foundation.
• Osteo Science FoundationcoreStrategic or Co-development PartnerLaunched in 2013 by Dr. Peter Geistlich and Geistlich Pharma, the Osteo Science Foundation is based in the U.S. and aims to support independent basic and applied research and enable new therapeutic approaches and clinical treatment methods in regenerative dentistry.
• ON FoundationcoreStrategic or Co-development PartnerFounded in 2018 by Dr. Andreas Geistlich and Geistlich Pharma in the field of orthoregeneration, the ON Foundation connects young professionals, experts, and orthopedic professional associations worldwide to advance the field of orthoregeneration.
• Loma Linda University / Prof. Dr. Philip J. BoynecoreStrategic or Co-development PartnerDr. Peter Geistlich worked closely with Prof. Dr. Philip J. Boyne from Loma Linda University in California, whose pioneering work in bone regeneration led to the development of Geistlich Bio-Oss. This collaboration laid the foundation for the field of regenerative dentistry.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Organogenesis Holdings: Regenerative medicine company focused on advanced wound care (Apligraf, Dermagraft) and surgical biologics. Comparable to Geistlich's Derma-Gide wound care line and Bio-Gide collagen membrane platform; both operate in regenerative tissue markets though Organogenesis is wound-care-led.
• MiMedx Group: Regenerative medicine company producing amniotic tissue allografts (EpiFix, AmnioFix) for wound care, surgical, and dental applications. Adjacent peer competing in regenerative dental soft-tissue and bone graft markets with an alternative (human-derived) tissue platform versus Geistlich's xenograft.
• Collagen Solutions: U.K.-based developer and manufacturer of medical-grade collagen and tissue components for regenerative medicine and dental applications. Direct process-level comparable to Geistlich Bio-Gide's collagen membrane manufacturing, supplying similar dental and surgical markets at a smaller scale.

Direct peers

• Botiss Biomaterials: Germany-based dental regeneration specialist offering bone graft substitutes (cerabone, maxresorb), collagen membranes (collprotect, Jason), and soft-tissue matrices. Closely comparable European peer to Geistlich with overlapping product categories and customer base in periodontics and implantology.
• Straumann Group: Global leader in dental implants and a broad regenerative dentistry portfolio (including bone graft substitutes and membranes). Straumann is Geistlich's most directly comparable peer — same customer base (periodontists, oral surgeons, implantologists), same sales motion, and overlapping product categories, though Straumann is implant-led while Geistlich is biomaterials-led.
• ZimVie: U.S. pure-play dental bone graft substitute and membrane manufacturer (RegenerOss, Biotex) spun out of Zimmer Biomet. Directly competes with Geistlich Bio-Oss and Bio-Gide in the North American regenerative dental market with similar products and customer profile.
• Integra LifeSciences: Specialty surgical and regenerative medicine company with meaningful dental regeneration (DynaMatrix, OraPharma) and wound care exposure. Competes with Geistlich Bio-Gide and Mucograft in dental soft-tissue regeneration and with Derma-Gide's former indications in advanced wound care.
• RTI Surgical: Tissue-based surgical implants manufacturer specializing in allograft bone grafts, sports medicine soft-tissue products, and dental regenerative materials. Competes with Geistlich Bio-Oss in bone grafting and with Geistlich's broader regenerative portfolio through surgical and dental channels.
• LifeNet Health: Non-profit tissue bank producing allograft bone grafts, dermal matrices, and sports medicine tissues. Directly comparable to Geistlich's xenograft-based bone substitute and collagen membrane portfolio, with similar clinical applications in dental and orthopedic regeneration.

Broad incumbents

• Dentsply Sirona: Largest diversified dental equipment and supplies manufacturer globally, serving the same dental professional customers as Geistlich. While Dentsply's portfolio spans implants, prosthetics, and instruments, it competes in regenerative dental materials through its MIS Implants subsidiary and distribution channels.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/geistlich-biomaterials-north-america
• Facebookfacebook.com/GeistlichNA

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Geistlich Biomaterials